课题基金 / 基金详情

Assessment of efficacy of Kampo medicines on Ulcerative colitis

Assessment of efficacy of Kampo medicines on Ulcerative colitis
汉方药治疗溃疡性结肠炎的疗效评价
批准号:
20790481
负责人:
ENDO Mari
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009

项目摘要

项目成果

ENDO Mari的其他基金

相关文献

中文摘要
翻译
据报道,中药复方橙皮及其中草药S-r具有抑制直肠系小鼠结肠炎的作用。然而,在这一模型中,还没有关于任何其他Kampo药物可能具有直接抗炎活性的研究。没有关于省略一种特定草药的Kampo药物的效果的现有信息。在我们对不同Kampo制剂治疗DSS结肠炎的有效性的分析中,我们观察到Saireito(SRT)的抗炎活性抑制了结肠的缩短和髓过氧化物酶活性的下降。接下来,我们研究了SRT的两个成分Shosaikoto(SST)和Goreisan(GRS)的抗炎活性。在该模型中,SST和GRS均未表现出抗炎活性,提示SST和GRS的联合应用对SRT的抗炎活性是必要的。最后,我们检查了SRT在特定草药从配方中剔除后是否保留了其抗炎特性。从配方中去掉S-r后,SRT的抗炎活性仍然存在。或者,缺少柴胡(B-r)的SRT不保留任何抗炎活性。这些结果表明,SRT对DSS结肠炎的抗炎作用依赖于B-r的包被或B-r与其他中药的结合。
英文摘要
It has been reported that the herbal compound, Orengedokuto (OGT), as well as one of its herbal components, a Scutellariae radix(S-r), was able to suppress inflammation in a DSS-induced murine colitis (DSS colitis). However, there have been no studies of the effects of any other Kampo medicines that may have direct anti-inflammatory activity in this model. There is no available information regarding the effects of Kampo medicines that have been formulated with omission of a single specific herb. In our analysis of the effectiveness of various Kampo formulations in the treatment of DSS colitis, we observed suppression of the shortening of the colon and a decrease in Myeloperoxidase activity, which we believe to be due to the anti-inflammatory activity of Saireito (SRT). We next investigated the anti-inflammatory activity of Shosaikoto (SST) and Goreisan (GRS), which are the two components of SRT. Neither SST nor GRS alone showed anti-inflammatory activity in this model, indicating that the combination of these two compounds is necessary for the anti-inflammatory activity of SRT. Finally, we examined whether SRT retained its anti-inflammatory properties after specific herbs were eliminated from the formulation. The anti-inflammatory activity of SRT was still present after removal of S-r from the formulation. Alternatively, SRT that lacked Bupleuri radix (B-r) did not retain any anti-inflammatory activity. These results imply that the anti-inflammatory activity of SRT on DSS colitis is dependent on the inclusion of B-r or the combination between B-r and other herbs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
デキストラン硫酸ナトリウム誘発大腸炎モデルに対する漢方薬の有効性の検討
中草药对右旋糖酐硫酸钠诱导的结肠炎模型的有效性考察
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [遠藤真理, 及川哲郎, 羽鳥努, 花輪壽彦]
通讯作者: 花輪壽彦
デキストラン硫酸ナトリウム誘発大腸炎モデルマウスに対する漢方薬の有効性~BALB/cマウスとC57BL/6マウスの比較検討~
中草药对右旋糖酐硫酸钠诱导的结肠炎模型小鼠的疗效~BALB/c小鼠与C57BL/6小鼠的对比研究~
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [遠藤真理, 及川哲郎, 羽鳥努, 松本司, 花輪壽彦, 遠藤真理]
通讯作者: 遠藤真理
Suppression of murine colitis by Kampo medicines, with special reference to the efficacy of saireito
汉方药物对小鼠结肠炎的抑制作用,特别是 saireito 的功效
DOI: --
发表时间: 2009
期刊: Journal of Traditional Medicines. 26(3)
影响因子: --
作者: [Mari ENDO, Tetsuro OIKAWA, Takayuki HOSHINO, Tsutomu HATORI, Tsukasa MATSUMOTO, Toshihiko HANAWA, 遠藤真理]
通讯作者: 遠藤真理
Suppression of murine colitis by Kampo medicines, with special regerence to the efficacy of saireito.
汉方药物对小鼠结肠炎的抑制作用,特别关注saireito的功效。
DOI: --
发表时间: 2009
期刊: J Trad Med 26(3)
影响因子: --
作者: [Mari ENDO, Tetsuro OIKAWA, Takayuki HOSHINO, Tsutomu HATORI, Tsukasa MATSUMOTO, Toshihiko HANAWA]
通讯作者: Toshihiko HANAWA
13C-butyrate breath-test is a new non-invasive method for assessing colitis in murine model
  • 批准号:
    23790752
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $1.41万
  • 财政年份:
    2011
  • 负责人:
    ENDO Mari
  • 依托单位: